StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
William Blair Downgrades Biogen (BIIB) to Market Perform
March 21, 2019 8:27 AM
William Blair analyst Matt Phipps downgraded Biogen (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright
March 25, 2019 7:49 AM
Mizuho Securities Downgrades Biogen (BIIB) to Neutral
March 21, 2019 10:06 AM
Biogen (BIIB) PT Lowered to $275 at Cowen
March 21, 2019 9:20 AM
Biogen (BIIB) fair value is $241/share without AD - Citi
March 21, 2019 8:28 AM
